Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Neurodegeneration and Proteostasis

Available via

WEBINAR

Neurodegeneration and Proteostasis

Monday, March 7, 2022, 8:30 AM - 6:00 PM EST

New York City

Presented By

The New York Academy of Sciences

AbbVie Inc

 

With an aging population worldwide, neurodegenerative diseases such as Alzheimer’s and Parkinson’s are on the rise. Today more than 7 million individuals in the US alone are affected by neurodegeneration. However, the current options to treat neurodegenerative brain diseases are still very limited. Therefore, the need to identify new therapeutic avenues is very urgent.

Proteostasis biology provides a promising new direction for such novel therapeutic avenues. The understanding of the biological processes underlying proteostasis has advanced considerably within the last decade, notably with the 2016 Nobel Prize in Medicine awarded for work on autophagy.

This symposium will bring together experts in proteostasis biology and neurodegenerative disease, along with clinicians, drug developers, and investors to consider how to apply the emerging science of proteostasis to deliver transformational therapies for neurodegenerative disease.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, January 7, 2022.

Deadline:
79
days
left

Scientific Organizing Committee

Ana Maria Cuervo, MD, PhD

Albert Einstein College of Medicine

Jeffery Kelly, PhD

The Scripps Research Institute

Matthew Townsend, PhD

AbbVie Inc.

Sonya Dougal, PhD

The New York Academy of Sciences

Barbara Knappmeyer , PhD

The New York Academy of Sciences

Speakers

Ana Maria Cuervo MD, PhD

Albert Einstein College of Medicine

Fiona Elwood, PhD

Novartis Institutes for BioMedical Research

Steven Finkbeiner, MD, PhD

University of California, San Francisco

Judith Frydman, PhD

Stanford University

Katherine A. High, MD

Ask Bio

Peter T. Lansbury, PhD

Harvard University, Bial Biotech

Richard I. Morimoto, PhD

Northwestern University

Ralph A. Nixon, MD, PhD

NYU Langone Health

David Rubinsztein, PhD

University of Cambridge

Luke Wiseman, PhD

The Scripps Research Institute

Ai Yamamoto, PhD

Columbia University

Richard J. Youle, PhD

National Institute of Neurological Disorders and Stroke